Vincerx Pharma Inc expected to post a loss of 58 cents a share - Earnings Preview

Vincerx Pharma

07/08/2023 13:48

* Vincerx Pharma Inc  VINC.OQ   VINC.O  is expected to show
no
change in quarterly revenue when it reports  results on August 9
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Vincerx Pharma Inc
is for
a loss of 58 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 14.7%
in the last three months. ​
    * Wall Street's median 12-month price target for Vincerx
Pharma
Inc is $5​, above​ its last closing price of $0.90. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.61       -0.60                        
 Mar. 31 2023  -0.52       -0.52      -0.68     Missed  -30.8
 Dec. 31 2022              -0.61      -0.65     Missed  -5.7​
 Sep. 30 2022  -0.64       -0.55      -0.80     Missed  -44.8
 ​​Jun.        -0.82       -0.79      -0.88     Missed  -10.7
 30 2022                                                
 Mar. 31 2022  -0.72       -0.76      -0.79     Missed  -4.5​
 Dec. 31 2021  -0.87       -0.93      -0.31     Beat    66.7
 Sep. 30 2021  -0.86       -0.85      -1.39     Missed  -63.9
 This summary was machine generated August 7 at 12:48 GMT.  All
figures in US dollars  unless otherwise stated